scientific program - World Allergy Organization

More documents

Recommendations

Info

MONDAY 68 WAO Congress–XVIII ICACI Final Program P-4-22 Oropharyngeal vaccinia virus presence after smallpox vaccination Klote MM1 , Ludwig G2 , Hershey J1 , Black L1 , Engler RJM1 , Martin BL1 1Walter Reed Army Medical Center, Washington, DC, USA, 2United States Army Medical Institute of Infectious Diseases, Ft. Detrick, MD, USA O-13-1 Effect of Mycoplasma pneumoniae on IL-8 gene expression from human respiratory epithelial cells Sohn MH1 , Lee KE1 , Kim KE1 1Yonsei University College of Medicine, Seoul, Republic of Korea Skin Disease and Dermatitis P-5-1 The effect of a probiotic on intestinal permeability in childhood eczema Gold M1 , Keatley D1 , Butler R1 1Adelaide University Department of Paediatrics, Adelaide, South Australia, Australia P-5-2 Serum eotaxin level in patients with atopic dermatitis syndrome Paluchowska B1 , Targowski T2 , Jahnz-Rozyk K2 , Zabielski S1 , Plusa T2 1Department of Dermatology, Military Institute of Medicine, Warsaw, Poland, 2Department of Allergology, Military Institute of Medicine, Warsaw, Poland P-5-3 Bedding endotoxin levels are inversely related to disease severity in children with atopic eczema Siebers R1 , Kelly R1 , Sistek D1 , Stanley T2 , Fitzharris P1 , Crane J1 1Wellington Asthma Research Group, Wellington, New Zealand, 2Wellington Hospital, Wellington, New Zealand P-5-4 Expression of cysteinyl leukotriene receptor-1 in atopic dermatitis and psoriasis skin lesions Hussain I1 , Stone M1 , Kitagaki K1 , Businga T1 , Kline J1 1University of Iowa, Iowa City, IA, USA P-5-5 Fexofenadine effectively suppresses the spontaneous scratching behavior in NC/Nga mice (a model of human atopic dermatitis) Watanabe N1 , Wada A1 , Matsuda H2 , Takahashi H3 , Igarashi M3 , Tateda C3 1 2 The Jikei University School of Medicine, Tokyo, Japan, Tokyo University of Agriculture and Technology, Tokyo, Japan, 3New Drug Development Research Center, INC, Hokkaido, Japan P-5-6 Optimal treatment of atopic dermatitis: a telemedical approach Bolle R1 , Danielsen I1 , Nyheim B1 1University Hospital North-Norway, Tromso, Norway P-5-7 Forty cases with contact allergy to topical corticosteroids Kato YK1 , Sugiura MS1 , Hayakawa RH1 1Environmental Dermatology, Nagoya University, Nagoya, Japan P-5-8 Resting energy expenditure, oxygen consumption, and carbon dioxide production in children with atopic dermatitis Hon KL1 , Leung TF1 , Ma KC1 , Wong Y1 , Yin JA1 , Fok TF1 , Li MC1 MONDAY, 8 SEPTEMBER - continued 1Prince of Wales Hospital, Hong Kong, Hong Kong POSTER SESSIONS P-5-9 The involvement of staphylococcal superantigen in spinal and duodenal lesions in patients with atopic dermatitis Sugimoto K1 , Shimojo N2 , Terano T3 , Kubosawa H4 , Hattori T5 , Ito S5 , Ishikawa N1 1Department of Pediatrics, Chiba Municipal Hospital, Chiba, Japan, 2Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan, 3Department of Internal Medicine, Chiba Municipal Hospital, Chiba, Japan, 4Department of Clinical Pathology, Chiba Municipal Hospital, Chiba, Japan, 5Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan P-5-10 Effect of antihistamines on astaetotic eczema Takeda K1 , Tachikawa N2 1Keijyu Medical Center, Department of Dermatology, Nanao, Ishikawa, Japan, 2Keijyu Medical Center, Department of Dermatology, Nanao, Ishikawa, Japan P-5-11 A case series of montelukast as a therapeutic agent for atopic dermatitis in children Hon KL1 , Leung TF1 , Ma KV1 , Wong Y1 , Li AM1 , Fok TF1 1Prince of Wales Hospital, Hong Kong, Hong Kong P-5-12 A pilot study of an amino acid-based milk formula in treating young children with atopic dermatitis Leung TF1 , Cheung LTF2 , Ma KC1 , Wong E3 , Wan H1 , Hon KL1 , Fok TF1 1Department of Pediatrics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 2Dietetic Department, Prince of Wales Hospital, Hong Kong, Hong Kong, 3Center for Clinical Trials and Epidemiological Research, C.U.H.K., Hong Kong, Hong Kong P-5-13 Change of QOL score (SF-36 Japanese version) in patients with atopic dermatitis according to medical treatment Fukuroku K1 , Nagano T2 , Ogino S1 1School of Allied Health Sciences, Faculty of Medicine, Osaka University, Osaka, Japan, 2Nagano Dermatology Allergology Clinic, Osaka, Japan P-5-14 Decreased cutaneous lymphocyte antigen (CLA) +CD4+ T cells in children with severe atopic dermatitis after the treatment of cyclosporin Lee SY1 , Kim JH1 , Kim BS1 , Choi SO2 , Jang SO2 , Hong SJ1 1Asan Medical Center, College of Medicine, Ulsan University, Seoul, Republic of Korea, 2Asan Institute for Life Science, Seoul, Republic of Korea P-5-15 Expression of B7:1 (CD80) and B7.2 (CD86) in atopic dermatitis and correlation with IgE synthesis Kim MN1 , Tak WJ1 , Kim BJ1 , Hong CK1 1Department of Dermatology, College of Medicine, Chung Ang University, Seoul, Republic of Korea P-5-16 The role of staphylococcal superantigens in the pathogenesis of atopic dermatitis Lehmann HS1 , Mallon DFJ2 1Telethon Institute for Child Health Research, Subiaco, WA, Australia, 2Princess Margaret Hospital, Subiaco, WA, Australia P-5-17 Treatment of severe atopic dermatitis with cyclosporin A in 2002 Nowicki R1 , Baranska-Rybak W1 1Department of Dermatology, Venerology and Allergology, Gdansk, Pomorskie, Poland P-5-18 Extrinsic and intrinsic type atopic dermatitis: local experience at an allergy clinic in the Philippines Vicencio JV1 , Gonzalez-Andaya AM1 1University of Santo Tomas Hospital, Manila, Philippines
WAO Congress–XVIII ICACI Final Program MONDAY, 8 SEPTEMBER - continued POSTER SESSIONS P-5-19 Treatment of infants with atopic dermatitis with pimecrolimus cream 1% improves parents’ quality of life Staab D1 , Kaufmann R2 , Foelster-Holst R3 , Hoeger P4 , Thaci D2 , Wahn U5 1 2 Krankenhaus Zehlendorf, Berlin, Germany, Johann Wolfgang Goethe Universität, Hautklinik, Frankfurt, Germany, 3Christian- Albrechts-Universität, Hautklinik, Kiel, Germany, 4Universitätsklinikum Eppendorf, Hautklinik, Hamburg, Germany, 5 P-5-20 Charite-Virchow Klinikum, Kinderklinik und Poliklinik, Berlin, Germany The characteristic of the immune status parameter in atopic dermatitis in children Andreeva II1 , Petrov SS1 1State Medical University, Rostov-on-Don, Russian Federation P-5-21 Pimecrolimus cream 1%: bridging clinical trials into clinical practice Langley R1 , Friedlander S2 , Ring J3 , Wuethrich B4 , Leclerc P5 , McGeown C6 , On behalf of the NOBEL Study Group 1Dalhousie University, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada, 2Children’s Hospital, San Diego, CA, USA, 3Technische Universität, Muenchen, Germany, 4 5 Universitätsspital, Zurich, Germany, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 6Novartis Pharma AG, Basel, Switzerland P-5-22 Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants: a 2-year cohort study Papp K1 , Potter P2 , Kapp A3 , de Prost Y4 , Goertz HP5 , Paul C5 1Probity Medical Research, Waterloo, Ontario, Canada, 2Allergology, Diagnostic & Clinical Research Center, Cape Town, South Africa, 3Hannover Medical University, Hannover, Germany, 4 5 Necker Hospital for Sick Children, Paris, France, Novartis Pharma AG, Basel, Switzerland P-5-23 Pimecrolimus cream 1% significantly improves atopic dermatitis in infants aged 3-23 months within 3 days of treatment Kaufmann R1 , Foelster-Holst R2 , Hoeger P3 , Thaci D1 , Braeutigam M4 , Wahn U5 1J. W. Goethe-Universität, Hautklinik, Frankfurt, Germany, 2Christian-Albrechts-Universität, Hautklinik, Kiel, Germany, 3Universitätsklinikum Eppendorf, Hautklinik, Hamburg, Germany, 4Novartis Pharma GmbH, Clinical Research, Nuernberg, Germany, 5Charite-Virchow Klinikum, Kinderklinik und Poliklinik, Berlin, Germany P-5-24 Patch testing: a six years experience Mateo Borrega MB1 , Sanz SG2 , Camacho D3 , Otero D3 1Allergy Unit, Unmequi Sanatorios SL & Clínica Dr. Sanz Vázquez, Guadalajara, Guadalajara, Spain, 2Allergy Unit, Centro Médico La Paloma, Torrejón de Ardoz, Madrid, Spain, 3Dermatology Unit, Unmequi Sanatorios SL, Guadalajara, Guadalajara, Spain P-5-25 Linkage between the occurrence of the anticardiolipin IgM and mite allergen specific IgE antibodies in children with atopic eczema/dermatitis syndrome Szakos E1 , Lakos G2 , Alexa M2 , Hunyadi J3 , Sólyom E1 , Sipka S2 , Gyimesi E2 1Borsod-A-Z County and University Teaching Hospital, Pediatric Health C, Miskolc, Hungary, 23rd Department of Internal Medicine, University of Debrecen, Debrecen, Hungary, 3Department of Dermatology, University of Debrecen, Debrecen, Hungary 69 P-5-26 Lymphocyte composition of dermal infiltrates in chronic atopic dermatitis Drannik GN1 , Kurchenko AI1 , DuBuske LM2 1 2 National Medical University, Kiev, Ukraine, Immunology Research Institute of New England, Fitchburg, MA, USA P-5-27 Dermatological evidence of the use of alternative therapies in some allergic respiratory disorders Wong HCG1 , Wong NYY1 1University of British Columbia, Vancouver, BC, Canada P-5-28 A case of pigmented purpuric eruption successfully treated with oral cyclosporin A Taskapan MO1 , Dogan B1 , Harmanyeri Y1 1GATA H. Pasa Teaching Hospital, Dept. of Dermatology-Allergy, Acibadem-Istanbul, Turkey Joggers in Stanley Park MONDAY
Page 1:
FINAL PROGRAM World Allergy Organiz
Page 4 and 5:
2 WAO Congress-XVIII ICACI Final Pr
Page 6 and 7:
4 World Allergy Organization (WAO)-
Page 8 and 9:
6 WAO Congress-XVIII ICACI Final Pr
Page 10 and 11:
8 sneezing runny nose itchy nose it
Page 12 and 13:
10 PRECAUTIONS (continued) ADVERSE
Page 14 and 15:
12 WAO Congress-XVIII ICACI Final P
Page 16 and 17:
Page 18 and 19:
Page 20 and 21: 18 WAO Congress-XVIII ICACI Final P
Page 23 and 24: WAO Congress-XVIII ICACI Final Prog
Page 25 and 26: Whistler alpine resort WAO Congress
Page 29 and 30: XXIII EAACI Congress 12-16 June 200
Page 31 and 32: 7:00 8:00 9:00 10:00 11:00 12:00 13
Page 49 and 50: WEDNESDAY WEDNESDAY SEPTEMBER SEPTE
Page 51 and 52: www.annualmeeting.aaaai.org Visit w
Page 59 and 60: Presenting authors indicated in bol
Page 61 and 62: FRIDAY, 12 SEPTEMBER WAO Congress-X
Page 63 and 64: Imagine research targeting IgE, a k
Page 69: WAO Congress-XVIII ICACI Final Prog
Page 98 and 99: 96 PLAN TO ATTEND! SOYEZ DES NÔTRE
Page 100 and 101: 98 Dolovich, Myrna Canada BR86 Dubo
Page 102 and 103: 100 Schnuch, Axel Germany BR88 Scho
Page 104 and 105: 102 201 ACII - Journal of the World
Page 106 and 107: 104 WAO Congress-XVIII ICACI Final
Page 116 and 117: 114 Crowne Plaza Hotel Georgia 801
Page 120 and 121:
118 (salmeterol xinafoate/fluticaso
Page 122 and 123:
COPD, the most commonly reported dr
Page 124 and 125:
122 WAO Congress-XVIII ICACI Final
Page 126 and 127:
124 Seaplane landing at sunset Gran
Page 128:
DS2 - Dinner Symposium Monday, 8 Se
show all

scientific program - World Allergy Organization

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?